AABB interviewed Yoga Balaji, MS, MBA, founder and CEO at Pragmatrix, a participating organization in the Biotherapies Pavilion at the 2025 AABB Annual Meeting. Read the interview below to learn more about the Pragmatrix team.
My name is Yoga Balaji, and I'm the founder and CEO of Pragmatrix. I was born in India. I have lived in the United States for nearly 30 years, currently residing in Chicago. My entire career has been driven by one core conviction: to serve patients using the skills I possess - which includes software development. Having served as chief technology officer at Mediware Information Systems, I founded Pragmatrix in 2006 with a goal to leverage software to directly eliminate errors in health care, significantly improve patient safety and make it inherently easy to comply with complex regulations.
Pragmatrix was founded in 2006, and our non-negotiable mission is to help patients by empowering the stakeholders and organizations that serve them. We achieve this by relentlessly focusing on efficiency improvement and process efficiency to eliminate errors for all patient-centric organizations.
We provide the PragLife (Pragmatrix Life Sciences) suite, a comprehensive set of applications that automate processes from research and development through commercial operations. We specialize in ensuring absolute compliance with critical mandates like cGMP, 21 CFR Part 11, HIPAA (for ePHI management) and requirements for ALCOA+ data integrity. While headquartered in Chicago, our diverse team operates remotely from hubs across the United States, the United Kingdom and India, giving us a global perspective on these health care challenges.
We tackled two major challenges. First, solving the issue of the software fit for rapidly evolving sectors like cell and gene therapy, contract development and manufacturing organizations, and contract manufacturing organizations. We innovated our PragLife architecture into a modular, flexible platform - a "choose modules you need" and "scale as you grow" model - which allows all organizations to implement workflow automation quickly. The second challenge is changing the market's perception of implementation complexity. We prove daily that, unlike old systems, our highly tailorable solution can be implemented in just four to six months, accelerating error elimination across the board.
Our goals for this year and next are to accelerate automation and expand our global reach with our PragLife platform, leveraging our rapid four-to-six-month deployment model.
What genuinely excites me is how artificial intelligence is redefining technology and therapeutics. We are rapidly rolling out new AI-powered features to directly improve diagnostic effectiveness for clinicians, ensuring more personalized and effective treatments for patients and pushing accuracy well beyond current cGMP requirements.
Critically, the PragLife platform is designed for ultimate configurability. Whether clients are working on precision mRNA therapies or complex iPSC regenerative medicine, our software is the single, unified platform that can manage any therapeutic workflow - like having the same high-speed racetrack designed for every type of vehicle. This technological leap is connecting the future of medicine.
Pragmatrix has been a long-time supporter of AABB, and our collaboration solidified when we hosted a booth in the Biotherapies Pavilion at the 2025 AABB Annual Meeting. We see AABB's role as enormous and indispensable. AABB is the essential umbrella, facilitating critical functions: establishing standards and accreditation that guide our PragLife development; providing crucial knowledge sharing and workforce development (like the CABP credential); and driving advocacy and regulatory updates for mandates like 21 CFR Part 11. AABB ensures our technology remains compliant and effective, accelerating the delivery of life-saving therapies.
The most rewarding part of the biotherapies field boils down to one simple, profound concept: human assistance—the deep satisfaction that comes from knowing our work directly impacts another human being. You don't have to be a doctor or scientist; an engineer, a quality assurance specialist or the architect of a platform like PragLife is equally assisting the patient.
For us at Pragmatrix, the reward is seeing our software create a chain of empathy. By ensuring data integrity, eliminating errors and accelerating deployment (our four-to-six-month implementation), we are ultimately speeding up the delivery of safe, life-saving treatments.
My critical advice to anyone starting out is this: always see the fellow human in need. Don't just focus on the technology or the process; see the patient who will receive the product. That perspective shifts your work from a technical task to a moral imperative. That mindset makes us think better, work harder, and drives us to achieve the highest standards of cGMP and patient safety in everything we do. In this field, empathy is the greatest driver of excellence.
Register your interest in biotherapies sponsorships, connection packages and other opportunities at the 2026 Annual Meeting, taking place October 17-19, in Atlanta, GA.
4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977
